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ABSTRACT
The microbiome is a dynamic community that can positively and negatively influence 
host health. Lactobacillus reuteri is a probiotic that has received much attention for 
its ability to inhibit pathogens such as Salmonella typhimurium, Escherichia coli, and 
Clostridium difficile. It does so by its unique ability to metabolize glycerol into the 
antimicrobial compound 3-HPA, which is commonly referred to as reuterin. The ability 
to secrete reuterin is dependent not only on glycerol availability but also the concentration 
of glucose. In fact, there appears to be a “goldilocks” ratio between glucose and glycerol 
as either too much or too little glucose significantly diminishes reuterin production. Since 
L. reuteri primarily resides in distal regions of the intestine and colon where most of the 
glucose has already been absorbed, it seems unlikely that reuterin production would be 
promoted at the physiological level via this mechanism.
Prebiotics are carbohydrates that are indigestible by the host and remain for enzymatic 
digestion by intestinal probiotics. Inulin and galactooligosaccharides (GOS) are two 
widely studied prebiotics that are known for their ability to promote the growth of a 
wide range of Lactobacilli, and have been shown to promote L. reuteri growth to varying 
degrees. Here, we asked if prebiotics such as inulin and GOS promote the production 
of reuterin in the absence of glucose. L. reuteri were cultured in TSB with or without 
glycerol in the presence of glucose, inulin, or GOS and assessed for their ability to 
produce reuterin. While inulin did not enhance the production of reuterin, GOS induced 
reuterin production, although 45% less than that of glucose. Moreover, unlike the dose-
dependence observed with glucose, incubation with GOS induced similar reuterin 
production regardless of concentration. This suggests that an enzymatic equilibrium may 
exist where glucose/galactose is cleaved from GOS only as needed by L. reuteri.
Finally, to confirm the biopotency of reuterin production, we cultured S. typhimurium with 
supernatants from L. reuteri that were grown with various carbohydrates. Supernatant 
dilutions as low as 1:15 were able to significantly retard growth of S. typhimurium with 
ratios of 1:1 completely inhibiting growth. Together, these results suggest that prebiotics 
such as GOS may be able to elicit physiologically relevant production of reuterin, which 
may shape the flora of the microbiome and reduce incidence and severity of pathological 
infections. Further, as GOS are particularly abundant in breast milk, it suggests a possible 
link for early immunoprotection from intestinal pathogens while the infant is still 
immunologically naïve.
Keywords: Lactobacillus reuteri, Salmonella typhimurium, inulin, 
Galactooligosaccharides (GOS), reuterin, metabolism, prebiotics, probiotic 
INTRODUCTION
Microbiome: Influence on health
The interaction and effects between human health and the microbiota have been widely 
studied (D’Argenio and Salvatore, 2015; Gibson and Roberfroid, 1995). Improper 
balances in the composition of the microbiome can lead to deleterious effects on the 
host. For example, obesity has been correlated with elevated levels of pathogenic 
bacteria in the gut (Fei and Zhao, 2013). One study in particular looked at the ratio 
of one specific probiotic, Bifidobacteria, and one specific pathogen, Escherichia coli. 
They found that a group of obese school aged children had a significantly lower ratio 
of probiotics to pathogens (Gao et al., 2015). Other negative outcomes associated with 
unhealthy gut bacterial composition are inflammatory bowel disease (D’Argenio and 
Salvatore, 2015) and chronic heart failure (Pasini et al., 2016). In contrast to poor 
gastrointestinal conditions, symbiotic bacteria have been seen to ameliorate certain 
conditions such as constipation (Bekkali, Bongers, Van den Berg, Liem, and Benninga, 
2007; Coccorullo et al., 2010; Ojetti et al., 2014), obesity (Chen et al., 2014; National 
Human Genome Research Institute, n.d.), and can inhibit pathogens in vitro (De 
Weirdt et al., 2012) and in vivo (Uraipan and Hongpattarakere, 2015). These beneficial 
bacteria are referred to as probiotics which can be defined as living organisms that 
convey beneficial health to the host or support a proper equilibrium of autochthonous 
microbes within the gastrointestinal tract (Uraipan and Hongpattarakere, 2015). Two 
genera most commonly studied for their favorable effects upon human health are 
Bifidobacteria and Lactobacilli.
 
Probiotics generally exert their positive shift in a balanced microbiome in one of two 
ways. The first is through occupying a physical niche within the gut by which they 
are able to limit any pathogen adherence to intestinal walls. The second mechanism 
involved in probiotic activity is in the secretion of an antimicrobial substance that 
inhibits pathogen (De Weirdt et al., 2012; Kšonžeková et al., 2016). The secreted anti-
microbial typically either kills pathogenic organisms, or it prevents adherence to intes-
tinal walls thereby preventing niche establishment; both mechanisms effectively shift 
the gastrointestinal equilibrium. Probiotics produce microbial inhibition by excreting 
exopolysaccharides, which are polysaccharides on the cell surface of gram positive 
bacteria that then can be released into the adjacent vicinity (Chapot-Chartier and Ku-
lakauskas, 2014), or other compounds with antimicrobial properties including bacteri-
ocin peptides (De Weirdt et al., 2012; Kšonžeková et al., 2016; Schaefer et al., 2010; 
Silva Sabo, Converti, Todorov, Domínguez, and Souza Oliveira, 2015). Because of 
probiotics’ anti-pathogenic properties and correlation with health, much research has 
focused on elucidating how they may be promoted.
In the pursuit of enhancing the endogenous probiotic populations of the gut, a new 
category of compounds was outlined. Gibson and Roberfroid first coined the term 
prebiotics to describe these compounds, and characterized them as nondigestible food 
stuffs that selectively promote the growth or activity of bacteria that beneficially im-
pact the health of the host (Gibson and Roberfroid, 1995). Further delineation can be 
made between fibers and prebiotics by clarifying that fibers cannot be fermented in the 
gut while prebiotics are fermentable compounds (Stewart, Savarino, and Slavin, 2009). 
There are a number of prebiotics that have been studied including different types of 
fructans and oligosaccharides. These prebiotics selectively promote the growth of 
probiotics (Chung et al., 2016), mainly the genera Bifidobacteria and Lactobacillus 
(Kneifel, 2000; Kolida, Tuohy, and Gibson, 2002). 
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Changes in the microbiome have also been observed in human subjects due to prebi-
otics. For example, Costabile et al. administered different prebiotics to humans to see 
how they would impact the microbiota. While the overall number of bacteria remained 
the same, specific probiotics such as Bifidobacteria and Lactobacillus increased de-
pending on the particular prebiotic used. At the same time, bacteria associated with an 
unhealthy gut, such as Clostridia and Bacteroides, decreased in number (Costabile et 
al., 2010). Not only do prebiotic effect bacterial distribution, but Tarr et al. have also 
observed a significant impact on health. Mice were subjected to a variety of conditions 
involving stress and prebiotics, and not only did the addition of prebiotics help modu-
late the gut composition to keep it within a range of normal, but it also prevented the 
mice from becoming anxious when placed in stressor situations. (Tarr et al., 2015). 
Lactobacillus reuteri and the antimicrobial production of reuterin
Lactobacillus reuteri (L. reuteri) is a probiotic with promising potential. It has already 
been demonstrated to have health benefits in human studies, and studies like the ones 
conducted by Ojetti et al. and Coccorullo et al. have shown the potential advantageous 
outcomes associated with the L. reuteri (Coccorullo et al., 2010; Ojetti et al., 2014). In 
a double-blind, randomized, placebo controlled study by Coccorullo et al., supplemen-
tation of L. reuteri was investigated for its ability to alleviate the functional chronic 
constipation that some infants experience. Not only did they see a significant increase 
in bowel movements, but there was also no observed adverse effect resulting from the 
added probiotic (Coccorullo et al., 2010). Another essential benefit of L. reuteri’s pro-
biotic capacity is in its inhibition of pathogenic activity. One mechanism of inhibition 
is by limiting the ability of pathogens to adhere to gut epithelial cells. One group of 
researchers demonstrated that L. reuteri produced an exopolysaccharide that limited 
E. coli’s ability to adhere to porcine epithelial cells in vitro (Kšonžeková et al., 2016). 
This is in addition to the general characteristic of probiotics ability to occupy space 
that could otherwise be utilized by pathogens (Uraipan and Hongpattarakere, 2015). 
Another intriguing aspect of L. reuteri’s probiotic ability is its unique metabolism of 
glycerol into reuterin. De Weirdt et al. observed that the supernatant from L. reuteri 
produced antimicrobial effects against Salmonella typhimurium.  In this study, they 
subjected S. typhimurium to a variety of supernatant concentrations from L. reuteri 
cultures. A 1:10 concentration of supernatant from L. reuteri grown in the presence 
of glycerol not only limited the adhesion of S. typhimuirum to other cells, but it also 
inhibited the actual growth of S. typhimurium in vitro. Moreover, it was determined 
that reuterin was the active antimicrobial compound that was secreted by L. reuteri (De 
Weirdt et al., 2012). 
Reuterin (Figure 1) is also known as 3-hydroxyproponal or 3-hydroxypropionalde-
hyde (Schaefer et al., 2010), and is produced by a glycerol dehydratase that is B12 
dependent (Talarico and Dobrogosz, 1990). It also is clear that reuterin is metabolized 
from glycerol and not due to an overall increased metabolism. The precise mechanism 
of reuterin’s inhibition is not fully understood though it has been seen to have a wide 
range of antimicrobial inhibition (Talarico and Dobrogosz, 1989), including the path-
ogenic Clostridium difficile, which is responsible for many extended hospitalizations 
(Schaefer et al., 2010). There are currently two hypotheses to explain its broad range 
of inhibition. The first is that reuterin inhibits the activity of ribonucleotide reductase 
(Cleusix, Lacroix, Vollenweider, Duboux, and Le Blay, 2007; Talarico, Casas, Chung, 
and Dobrogosz, 1988), the enzyme that synthesizes ribonucleotides in bacteria (Tor-
rents, 2014). The other proposed, and more widely accepted, hypothesis is that reuterin 
introduces oxidative stress to the cells. Schaefer et al. investigated the mechanism by 
which reuterin may exert its potential oxidative stress. They showed that E. coli that 
had mutations for a specific gene involved with oxidative stress were more susceptible 
to reuterin’s effect. Moreover, they also showed that excess cysteine in the media could 
mitigate the antimicrobial effects of reuterin, suggesting that retuerin is interacting 
with thiol groups (Schaefer et al., 2010). 
Inulin and Galactooligosaccharides
Inulin (Figure 1) is a known prebiotic that can promote the growth of probiotics. Found 
in foods such as chicory root, Jerusalem artichoke, banana, onion, and garlic, inulin is 
a polymer of carbohydrate that varies in its degrees of polymerization (Costabile et al., 
2010). It is mainly composed of fructose monomers linked by 1-2 β-glycosidic bonds 
of repeating length. This β-glycosidic linkage is what makes it indigestible by human 
gastrointestinal enzymes. An α-glucose moiety sometimes starts the polymer (Rober-
froid, 2005). Chung et al. meticulously verified the prebiotic activity of inulin for vari-
ous probiotics in vitro (Chung et al., 2016). These prebiotic effects have been observed 
in vivo as well. One such study was conducted with humans where half of the subjects 
were given inulin and half were given a placebo of maltodextrin. Fecal samples taken 
before and after revealed that the number of Lactobacilli and Bifidobacteria increased 
in the experimental group. This suggests that prebiotics, and specifically inulin, can be 
used to actively modulate the composition of the microbiome (Costabile et al., 2010). 
Not only can inulin be given directly, but it also can be incorporated into baked goods 
while still retaining its prebiotic activity, thus expanding its realistic use (Kleessen B 
Figure 1: Structures of Inulin, GOS, and Reuterin. Each of the three compounds of interest for this research is 
depicted in this image. The β-glycosidic bonds between the monomers in inulin and GOS can be seen. As well, the 
varying degree of polymerization for both carbohydrates is illustrated with the brackets. Reuterin is easily observed 
as a modified version of glycerol by its molecular structure. (Fisch, 2006; Klaas, n.d.; Pubchem, n.d.)
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et al., 2007). L. reuteri is known to respond to various prebiotics of which inulin is one 
(Kassim, Baijnath, and Odhav, 2014). 
Galactooligosaccharides (Figure 1)  (GOS) are naturally occurring carbohydrates in 
breast milk that are synthesized via a β-galactosidase enzyme (Macfarlane, Steed, 
and Macfarlane, 2008). GOS have β-glyosidic linkages between galactose moieties 
of repeating length, and most often terminate with a single glucose monomer (Austin, 
Bénet, Michaud, Cuany, and Rohfritsch, 2014). GOS can often vary in degrees of po-
lymerization from 2 to 10 (Macfarlane et al., 2008), and are known to be metabolized 
by at least two different strains of L. reuteri (Kneifel, 2000). 
 
Bacterial metabolism 
Although prebiotics such as inulin and GOS are known to enhance the growth of some 
strains of L. reuteri, it is uncertain how, or if, the metabolism of these prebiotics im-
pacts the overall metabolic state of the organism. Some evidence demonstrates that 
prebiotics have increased the amount of antimicrobial substances produced by probi-
otics. If this is true, the ingestion of prebiotics could become a medicinally important 
part of a person’s diet. Our research set out to determine if metabolism of prebiotics by 
L. reuteri significantly increase reuterin production. Specifically, we hypothesized that 
the addition of prebiotics such as inulin or GOS to L. reuteri would increase reuterin 
secretion and inhibit S. typhimurium growth. 
METHODS
Bacteria, compounds, and storage
Lactobacillus reuteri PTA 6475 were obtained from the American Type Culture Col-
lection (Manassas, VA) and were maintained by anaerobic culture on Tryptic Soy Agar 
plates. Salmonella typhimurium was obtained from Presque Isle Cultures (Erie, PA), 
and incubated aerobically on TSA plates.  Plated cultures were stored at 4° C for use 
throughout experiments. Further, 10% and 20% glycerol stocks were created for long-
term storage of cultures. Inulin from chicory root was obtained from Chem-Impex 
International, while GOS was acquired from Bimuno. Tryptic Soy Broth (TSB) was 
supplemented with 0.1% Tween 80 in all conditions as a surfactant to aid the growth 
of L. reuteri [2]. 
Reuterin production by supplementation of inulin
L. reuteri was inoculated in TSB and twelve hours later, tubes were measured by spec-
trophotometry (OD 596). Next, 180 μL of working solution (OD596 close to 0.1) was 
inoculated in triplicate into Falcon tubes containing 9 mL of either TSB, TSB with 
5.0% inulin (w/v), TSB with 20 mM glycerol, or TSB with 20 mM glycerol and 5.0% 
inulin. Cultures were incubated with shaking for sixteen hours at 37°C.  Following this 
incubation, L. reuteri, were pelleted by centrifugation at 1500 rcf for ten minutes. The 
supernatant was removed, and the pellets were suspended in 9 mL of the corresponding 
broth (TSB, TSB with 5.0% inulin, TSB with 100 mM glycerol, and TSB with 100 mM 
glycerol and 5.0% inulin). They were then incubated again for two hours at 37°C with 
shaking. Subsequently, each sample was centrifuged at 8000 rcf for ten minutes. From 
every tube, 4.5 mL of the supernatant was placed into another tube that had 4.5 mL of 
TSB to render a 1:1 ratio of supernatant to TSB. Additional controls included 9mL of 
broth that had not been cultured with L. reuteri (TSB, TSB with 100mM glycerol, and 
TSB with 5.0% inulin). All samples were inoculated with 180 μL from the S. typhi-
murium working solution which consisted of S. typhimurium culture with an OD596 
of 0.1. Initial experiments were then incubated in a 37°C shaking water bath for two, 
three, four, five, six, and seven hours.  At each time point, a 1 mL aliquot was taken 
from each of the samples and measured by spectrophotometry for their OD596.  All 
conditions were performed in triplicate.
Titration of Reuterin
To titrate reuterin production, the previously described protocols were repeated except 
the supernatant was diluted to 1:1, 1:5, 1:10, and 1:15.  Further, a 1 mL aliquot was 
removed only after four hours (during S. typhimurium growth) for spectrophotometric 
analysis. 
GOS as primary carbon source
Assays were carried out in a similar manner as stated previously. However, carbon 
restricted (glucose free) TSB media was used to make the GOS media. In the carbon 
restricted TSB, the following four concentrations of GOS (w/v) were added: 0.25% 
GOS, 0.25% GOS with glycerol, 2.0% GOS, and 2.0% GOS with glycerol. As previ-
ously noted, glycerol concentration started at 20 mM and then was brought up to 100 
mM for each control that had glycerol. The positive control was standard TSB, which 
contains 13.9 mM of glucose, supplemented with glycerol. The negative control in 
this experiment lacked L. reuteri supernatant, and it was used to assess uninhibited 
growth of S. typhimurium. A 1:5 ratio of supernatant to TSB was used to incubate the 
S. typhimurium. After four hours, the S. typhimurium cultures were assessed by the 
spectrophotometer at 596 nm. 
Statistical Analysis
The statistical analysis for all experiments was done with a student’s t test to determine 
significance of results. A p value < 0.05 was considered to be statistically significant. 
RESULTS
Effect of inulin on reuterin production
S. typhimurium was first grown in the experimental supplements inulin and glycerol to 
determine if in the absence of L. reuteri, any inhibition of growth would be observed. 
As shown in Figure 2, inulin and glycerol did not inhibit S. typhimurium growth. Fur-
thermore, as others have reported, Figure 2 demonstrates that when L. reuteri was grown 
without glycerol, and the supernatant was used to culture S. typhimurium, there is an ab-
sence of any detectable antimicrobial effect. Each S. typhimurium sample was measured 
for growth with the spectrophotometer at an OD596. These results indicate that inulin 
alone does not inhibit S. typhimurium growth (Figure 2). However, as shown in Figure 3, 
supernatants at a 1:1 dilution from L. reuteri cultured in the presence of glycerol inhibit S. 
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typhimurium growth for every time point after hour 2 (p<0.001). And while the addition 
of glycerol significantly inhibited the growth of S. typhimurium, the addition of inulin did 
not further affect this response at a 1:1 dilution as can be seen in Figure 3. 
 
Dilution assay
As a 1:1 dilution of supernatants from L. reuteri cultures resulted in complete inhibi-
tion of S. typhimurium, we asked if effects of inulin would be observed over smaller 
dilutions in order to more precisely understand reuterin production. Dilutions for glyc-
erol cultured L. reuteri with and without inulin were made at 1:1, 1:5, 1:10, and 1:15. 
S. typhimurium was then cultured in these varied supernatant dilutions, and the opti-
cal density of S. typhimurium was assayed after four hours of incubation. The steady 
increase of absorbance indicates that the dilutions were within the sensitive range of 
our assay’s measurable limits. There was no significant difference observed between 
supernatant from L. reuteri grown with glycerol or glycerol plus inulin for any of the 
dilutions (Figure 4). These data further suggest that the addition of inulin does not in-
crease reuterin production. Moreover, the dose dependent increase of absorbance indi-
cates that the dilutions were within the sensitive range of our assay’s measurable limits.
The data obtained from Figure 4 further suggests to reject the first hypothesis that 
suggested the addition of inulin would increase reuterin production. 
GOS as a primary carbon source
The supernatant of L. reuteri grown with GOS as the primary carbon source was used 
to determine whether L. reuteri can produce reuterin while metabolizing other carbo-
hydrate sources other than glucose. As expected, the supernatants without any glycerol 
supplementation did not inhibit S. typhimurium growth significantly (Figure 5).
  
While not as potent as TSB that contains glucose as a carbon source, the addition of 
glycerol to GOS as a primary carbon source, at both concentrations tested, significantly 
inhibited the growth of S. typhimurium (p<0.01). This suggests that L. reuteri can se-
crete reuterin while metabolizing carbohydrates other than glucose. Also, the negative 
control of the supernatant from glucose with glycerol was significantly lower than 
every other sample (p<0.05).
DISCUSSION
We were able to consistently recreate the study of reuterin’s inhibitory effects on S. 
typhimurium by De Weirdt et al. (De Weirdt et al., 2012). While no inhibitory ability 
was observed by the addition of inulin, it cannot be entirely ruled out that the metab-
olism of inulin does not promote any inhibitory reuterin production. Even though it is 
known that some L. reuteri species can use inulin (Kassim et al., 2014), metabolism 
was not confirmed in this study, and it is possible that the L. reuteri did not metabolize 
Figure 3: Glycerol with inulin supplementation did not increase inhibition of S. typhimurium. S. typhimurium 
growth was significantly inhibited by both supernatants that were extracted from L. reuteri cultures incubated with 
glycerol. However, there was no difference in inhibition between supernatants with glycerol vs.glycerol with inulin at 
a 1:1 ratio.
Figure 2: Glycerol and inulin alone do not inhibit the growth of S. typhimurium. S. typhimurium was cultured 
with or without glycerol and inulin and assessed for growth over seven hours of log growth. Supernatants from L. 
reuterin (L.r.) that were cultured with or without inulin were also cultured with S. typhimurium to assess inhibitory 
capacity. All samples were completed in triplicate.
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the inulin much, if at all, because it was in the glucose rich carbon environment of 
the TSB. Furthermore, other studies have shown that certain strains of L. reuteri do 
not metabolize inulin at all (Adebola, Corcoran, and Morgan, 2014; Kneifel, 2000). 
So while this research demonstrated for the first time that an addition of inulin does 
not increase the production of reuterin with or without glycerol, it did not answer the 
question of whether it would have if inulin were the sole carbon source in the media. To 
better construct a more thorough assay would require a carbon restricted media, which 
would shift L. reuteri to metabolize the inulin. However, the promise of continuing this 
line of experimentation may be limited. Two studies looked at the effect that a variety 
of prebiotcs had on different probiotics. These studies seem to imply that prebiotic uti-
lization is strain specific. For example, inulin was not well metabolized by the strains 
used in at least two studies (Adebola et al., 2014; Kneifel, 2000). Contrarily, Kassim 
et al. showed that some L. reuteri strains did metabolize inulin (Kassim et al., 2014). 
Nevertheless, the PTA 6475 strain used in this study has not been tested for its ability to 
metabolize inulin in any literature reviewed. Therefore, the PTA 6475 strain cannot yet 
be said with great confidence to metabolize inulin when in a carbon restricted media. 
This is one area of study yet to be explored.
 
A new direction to be followed is how other carbohydrate sources effect reuterin pro-
duction. One study particularly has already shown that carbohydrate sources can act 
synergistically to impact antimicrobial production (Tzortzis, Baillon, Gibson, and Ras-
tall, 2004). A logical continuation of this would be to extend a study to incorporate 
different prebiotics to see if they impact antimicrobial output. This is precisely what 
was done with the GOS assay. The carbon restricted media (no glucose) was supple-
mented with GOS as the primary carbon source for L. reuteri. A study conducted by 
Lüthi-Peng, Dileme, and Puhan demonstrated that reuterin synthesis is optimized at a 
particular glycerol to glucose ratio. Following this line of thought, their study would 
seem to insinuate that carbohydrate metabolism does indeed impact reuterin output 
(Lüthi-Peng, Dileme, and Puhan, 2002). Supported by this study, the GOS assay was 
completed in order to better determine the relationship between reuterin synthesis and 
carbohydrate metabolism. This research showed for the first time that reuterin can be 
metabolized without glucose being the primary carbon source.
  
Discovering L. reuteri’s ability to continue to synthesize reuterin with GOS as a prima-
ry carbon source brought great insight into this unique form of metabolism (Figure 5). 
Going forward, there is still much to continue to study. For one, there was a significant 
difference in inhibition between glucose and GOS as the carbon source. It is known 
that different factors impact the production of different metabolites. (Årsköld et al., 
2007). One study by Liu and Yu revealed that the ratio of glucose to glycerol can be 
optimized for the production of reuterin. (Liu and Yu, 2015). Future studies should 
determine whether there is an optimal ratio of GOS to glycerol in the same way that 
others have previously found the ideal glucose to glycerol ratio. 
Figure 4: Titration of reuterin production is not influenced by inulin supplementation. Supernatants were 
prepared from L. reuteri grown with glycerol and glycerol with inulin. Each were diluted accordingly before use 
in the assay. All dilutions inhibited S. typhimurium growth. There was no significant difference between glycerol and 
glycerol with inulin at any dilution (p>0.05).
Figure 5: Reuterin production with GOS as primary carbon source is sufficient to inhibit S. typhimurium 
growth. Both concentrations of GOS at 0.25% or 2% allowed for reuterin production to occur thus the inhibition. 
Though significant inhibition was observed, there was also significant difference between the negative control and the
GOS with glycerol
supernatants.
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